Antigen suppression of the in vitro development of plaque-forming cells to autologous erythrocyte antigens.
Peritoneal cell cultures from NZB and C57BL/6 mice develop large numbers of PFC directed against antigens present on bromelain-treated isologous erythrocytes. The development of these autoimmune PFC can be suppressed by the addition of small numbers of BrMRBC at the start of the culture period. The possibility that the development of the plaque is prevented by the presence of antigen in vivo is discussed.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D000961:Antilymphocyte Serum; D001324:Autoantigens; D001963:Bromelains / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D006462:Hemolytic Plaque Technique; D006736:Horses; D006801:Humans; D007165:Immunosuppression Therapy; D066298:In Vitro Techniques; D051379:Mice; D008814:Mice, Inbred NZB; D012756:Sheep; D013601:T-Lymphocytes / Q000276:immunology
D000941:Antigens; D000961:Antilymphocyte Serum; D001324:Autoantigens; D001963:Bromelains